Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Eur J Neurol. 2024 Jun;31(6):e16266. doi: 10.1111/ene.16266. Epub 2024 Mar 12.
Thalamic alterations have been reported as a major feature in presymptomatic and symptomatic patients carrying the C9orf72 mutation across the frontotemporal dementia-amyotrophic lateral sclerosis (ALS) spectrum. Specifically, the pulvinar, a high-order thalamic nucleus and timekeeper for large-scale cortical networks, has been hypothesized to be involved in C9orf72-related neurodegenerative diseases. We investigated whether pulvinar volume can be useful for differential diagnosis in ALS C9orf72 mutation carriers and noncarriers and how underlying functional connectivity changes affect this region.
We studied 19 ALS C9orf72 mutation carriers (ALSC9+) accurately matched with wild-type ALS (ALSC9-) and ALS mimic (ALSmimic) patients using structural and resting-state functional magnetic resonance imaging data. Pulvinar volume was computed using automatic segmentation. Seed-to-voxel functional connectivity analyses were performed using seeds from a pulvinar functional parcellation.
Pulvinar structural integrity had high discriminative values for ALSC9+ patients compared to ALSmimic (area under the curve [AUC] = 0.86) and ALSC9- (AUC = 0.77) patients, yielding a volume cutpoint of approximately 0.23%. Compared to ALSmimic, ALSC9- showed increased anterior, inferior, and lateral pulvinar connections with bilateral occipital-temporal-parietal regions, whereas ALSC9+ showed no differences. ALSC9+ patients when compared to ALSC9- patients showed reduced pulvinar-occipital connectivity for anterior and inferior pulvinar seeds.
Pulvinar volume could be a differential biomarker closely related to the C9orf72 mutation. A pulvinar-cortical circuit dysfunction might play a critical role in disease progression and development, in both the genetic phenotype and ALS wild-type patients.
丘脑改变已被报道为携带 C9orf72 突变的额颞痴呆-肌萎缩侧索硬化症(ALS)谱系患者的主要特征。具体而言,丘脑枕,一个高级丘脑核,是大型皮质网络的时间控制器,被假设与 C9orf72 相关的神经退行性疾病有关。我们研究了丘脑枕体积是否可用于 ALS C9orf72 突变携带者和非携带者的鉴别诊断,以及潜在的功能连接变化如何影响该区域。
我们使用结构和静息态功能磁共振成像数据研究了 19 名 ALS C9orf72 突变携带者(ALSC9+),这些患者与野生型 ALS(ALSC9-)和 ALS 模拟物(ALSmimic)患者精确匹配。使用自动分割计算丘脑枕体积。使用丘脑枕功能分区的种子进行种子到体素功能连接分析。
与 ALSmimic 相比(曲线下面积 [AUC] = 0.86)和 ALSC9-(AUC = 0.77)患者,丘脑枕结构完整性对 ALSC9+患者具有较高的鉴别价值,得出的体积截断值约为 0.23%。与 ALSmimic 相比,ALSC9-患者的丘脑枕前、下和外侧连接与双侧枕叶-颞叶-顶叶区域增加,而 ALSC9+患者没有差异。与 ALSC9-患者相比,ALSC9+患者的丘脑枕-枕叶连接的前、下丘脑枕种子减少。
丘脑枕体积可能是与 C9orf72 突变密切相关的差异生物标志物。丘脑枕皮质回路功能障碍可能在遗传表型和 ALS 野生型患者的疾病进展和发展中发挥关键作用。